Advancing towards a novel, highly accurate method for cervical cancer screening
Cervical cancer is a highly prevalent cancer, with approximately 500,000 new cases diagnosed each year. Shockingly, the number of individuals diagnosed with precursor lesions in the cervix—also known as cervical intraepithelial neoplasia (CIN)—is 20 times higher. As with many potentially malignant conditions, early diagnosis of cervical cancer can make all the difference in a patient’s life in terms of treatment outcomes. For this, developing effective, convenient, and easily available screening protocols for CIN and cervical cancer is of paramount importance.
Currently, the two ...











